GSK1838705A is a potent IGF-1R inhibitor.

Picropodophyllin (PPP) is a IGF-1R inhibitor.

R406 is a potent Syk inhibitor.

Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT).

Tandutinib is a potent FLT3 antagonist.

BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3.

AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3.

Masitinib is a novel inhibitor for Kit and PDGFRα/β.